FR2215953B2 - - Google Patents

Info

Publication number
FR2215953B2
FR2215953B2 FR7303925A FR7303925A FR2215953B2 FR 2215953 B2 FR2215953 B2 FR 2215953B2 FR 7303925 A FR7303925 A FR 7303925A FR 7303925 A FR7303925 A FR 7303925A FR 2215953 B2 FR2215953 B2 FR 2215953B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7303925A
Other languages
French (fr)
Other versions
FR2215953A2 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7303925A priority Critical patent/FR2215953B2/fr
Priority to DE19732319016 priority patent/DE2319016A1/de
Priority to GB1930673A priority patent/GB1384523A/en
Publication of FR2215953A2 publication Critical patent/FR2215953A2/fr
Application granted granted Critical
Publication of FR2215953B2 publication Critical patent/FR2215953B2/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7303925A 1973-02-05 1973-02-05 Expired FR2215953B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR7303925A FR2215953B2 (ja) 1973-02-05 1973-02-05
DE19732319016 DE2319016A1 (de) 1973-02-05 1973-04-14 Neue derivate des 1-(4'-fluorphenyl) -4-piperazinyl-butan-1-ons, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen
GB1930673A GB1384523A (en) 1973-02-05 1973-04-24 Oxime derivatives and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7303925A FR2215953B2 (ja) 1973-02-05 1973-02-05

Publications (2)

Publication Number Publication Date
FR2215953A2 FR2215953A2 (ja) 1974-08-30
FR2215953B2 true FR2215953B2 (ja) 1976-05-14

Family

ID=9114320

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7303925A Expired FR2215953B2 (ja) 1973-02-05 1973-02-05

Country Status (3)

Country Link
DE (1) DE2319016A1 (ja)
FR (1) FR2215953B2 (ja)
GB (1) GB1384523A (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren

Also Published As

Publication number Publication date
FR2215953A2 (ja) 1974-08-30
DE2319016A1 (de) 1974-08-08
GB1384523A (en) 1975-02-19

Similar Documents

Publication Publication Date Title
AU476761B2 (ja)
AU474593B2 (ja)
AU474511B2 (ja)
AU474838B2 (ja)
AU476714B2 (ja)
AU476696B2 (ja)
FR2215953B2 (ja)
AU477823B2 (ja)
AU477824B2 (ja)
AR200256A1 (ja)
AU471461B2 (ja)
AR193950A1 (ja)
AR195311A1 (ja)
AR195948A1 (ja)
AU476873B1 (ja)
AR196123Q (ja)
CH562646A5 (ja)
AU479404A (ja)
BG19748A1 (ja)
BG19338A1 (ja)
AU482267A (ja)
AU479562A (ja)
AU479539A (ja)
AU479522A (ja)
AU479521A (ja)